Enlivex Therapeutics Ltd
(ENLV)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,960 | -3,835 | -794 | -9,384 | -6,517 |
| Depreciation Amortization | 186 | 114 | 54 | 206 | 144 |
| Accounts receivable | 1,586 | N/A | 1,853 | 318 | 63 |
| Accounts payable and accrued liabilities | N/A | 129 | -99 | 114 | -58 |
| Other Working Capital | -116 | 440 | 1,354 | 1,040 | 221 |
| Other Operating Activity | -944 | 257 | -1,589 | 665 | 758 |
| Operating Cash Flow | $-5,248 | $-2,895 | $779 | $-7,041 | $-5,389 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -16,000 | -12,000 | -2,000 | -7,714 | -7,960 |
| PPE Investments | -538 | -166 | -39 | -189 | -159 |
| Sale Of Investment | N/A | N/A | N/A | N/A | 1,544 |
| Other Investing Activity | 0 | 0 | 0 | 1,544 | 0 |
| Investing Cash Flow | $-16,538 | $-12,166 | $-2,039 | $-6,359 | $-6,575 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 22,553 | 22,553 | 22,456 | 8,306 | 8,306 |
| Financing Cash Flow | $22,553 | $22,553 | $22,456 | $8,306 | $8,306 |
| Exchange Rate Effect | 106 | -124 | -1,053 | 826 | 875 |
| Beginning Cash Position | 5,524 | 5,524 | 5,524 | 9,792 | 9,792 |
| End Cash Position | 6,397 | 12,892 | 25,667 | 5,524 | 7,009 |
| Net Cash Flow | $873 | $7,368 | $20,143 | $-4,268 | $-2,783 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,248 | -2,895 | 779 | -7,041 | -5,389 |
| Capital Expenditure | -538 | -166 | -39 | -193 | -159 |
| Free Cash Flow | -5,786 | -3,061 | 740 | -7,234 | -5,548 |